This instructional course has been designed to provide conceptual and operational knowledge to the licensed clinician interested in the provision of inotropic medications. Administration of these drugs is becoming more common as the population ages and pressure increases to reduce CHF-related hospitalizations. For the licensed clinician involved in providing this valuable therapy, this course contains current practices for best patient outcomes. This course provides 2 contact hours of continuing education.
State Boards of Nursing have varying positions on the role of the LPN/LVN in the administration of inotropic therapy. A link to each state board of nursing is listed here. Competency requirements are obtained and maintained through the clinician's employer, facility or institution.
In early 2021, the Infusion Nurses Society (INS), recognized as the global authority in infusion therapy, released the updated Infusion Therapy Standards of Practice. The INS sets the accepted standards for infusion therapy practice for all healthcare settings. This course is based on the current best practices as defined by the Infusion Nursing Society and other governing agencies such as the CDC, and FDA.
Upon completion of this course, the participant should be able to:
Chapter 1: Heart Failure
Pamela Clark, CRNI, is an infusion nurse with the Houston Methodist Sugar Land Hospital. She has more than 35 years of experience in infusion therapy and infusion education with both licensed nurses and patients. Her experience spans multiple infusion settings including: acute care, long-term care, home infusion, and ambulatory infusion care. She also has experience in oncology and oncology research.Read Full Bio